According to the new regulations, Americans over the age of 18 should use it in cases where they do not have access to other drugs allowed in the United States.
Experts in the United States have found that the use of a vaccine against the new coronavirus of the American company Johnson & Johnson (J & J) can increase the risk of blood clots, in this regard, the use of this drug has been restricted in the United States. The corresponding statement was issued on Thursday by the Food and Drug Quality Administration under the U.S. Department of Health and Human Services.
The regulatory body has changed the wording in the previously issued permit for the use of this single-component vaccine in emergency circumstances. According to the new regulations, Americans over the age of 18 should use it in cases where they do not have access to other similar vaccines allowed in the United States or cannot use them for medical reasons. As specified in the document, it is possible to be vaccinated with a drug from J & J if “otherwise a person will not receive a vaccine from COVID-19.”
Experts have found that within one or two weeks after using the drug from J & J, under certain conditions, the risk of blood clots may increase, which is “potentially life-threatening.” The department stated that such cases are very rare.
The Janssen Johnson & Johnson-owned company’s appeal regarding the registration of its single-component coronavirus vaccine under an accelerated procedure in emergency circumstances was approved by the Department at the end of February 2021.
According to Johns Hopkins University, which conducts calculations based on information from federal and local authorities, more than 81.6 million cases of coronavirus infection have been detected in the United States since the beginning of the pandemic; more than 996.9 thousand people have died. According to both indicators, the country ranks first in the world.
